Navigation Links
23ème congrès européen sur l'Hypertension et la Protection Cardiovasculaire
Date:6/25/2013

233;té abordée dans l'étude SEVITENSION,[8] dont les premiers résultats ont été présentés lors d'une session de posters dans le cadre du congrès de l'ESH 2013.

L'étude SEVITENSION avait pour objectif de déterminer si l'association fixe olmésartan /amlodipine 40/10 mg pouvait réduire la pression artérielle centrale jusqu'à un niveau similaire à celui obtenu avec l'association du périndopril 8 mg et de l'amlodipine 10 mg, traitement utilisé dans l'étude CAFÉ. Les résultats montrent que non seulement cet objectif a été atteint, mais aussi que la réduction de la pression artérielle centrale était plus importante avec l'association fixe olmésartan /amlodipine 40/10 mg qu'avec l'association du périndopril 8 mg et de l'amlodipine 10 mg. Les autres mesures de la pression artérielle, brachiale conventionnelle ou en ambulatoire sur 24 heures, ont aussi confirmé la supériorité de l'association fixe olmésartan /amlodipine 40/10 mg. Par ailleurs, chez les trois quarts des patients (75,6%) traités avec l'association fixe olmésartan /amlodipine 40/10 mg, la pression artérielle était normalisée et donc inférieure au seuil recommandé par la Société Européenne d'Hypertension pour tous les patients hypertendus (PA<140/90 mmHg).[9] La proportion de patients ayant obtenu ce niveau de pression artérielle avec l'association du périndopril 8 mg et de l'amlodipine 10 mg était presque 20% plus faible (57,5%). "Depuis la publication de l'étude CAFÉ, la référence était l'association du périndopril 8 mg et de l'amlodipine 10 mg, c'est pourquoi nous avons comparé ce traitement de référence avec l'association fixe olm&
'/>"/>

SOURCE Daiichi Sankyo Europe GmbH
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
2. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
3. Global Leaders in Advanced Biofuels Industry Urge Congressional Leaders to Extend Critical Tax Provisions
4. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
5. PharmAthene Presents Update on SparVax™ rPA Anthrax Vaccine Program at the 2012 World Vaccine Congress
6. Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
7. ETEX Corporation to present at the 9th World Biomaterial Congress
8. Discovery Labs to Present AFECTAIR® Data at European Congress on Pediatric and Neonatal Ventilation
9. PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
10. The Legends that Contributed to Silicon Valleys Eminence Assemble for Frost & Sullivans Growth, Innovation and Leadership 2012 Congress
11. BIOCOM Announces Endorsement in 52nd Congressional District Race
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 Histogen, Inc., a regenerative medicine ... grown under simulated embryonic conditions, today announced that they ... Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary ... agreement is an amendment to the existing license between ...
(Date:1/14/2014)... Texas , Jan. 14, 2014 The ... and research medicinal plants and therapeutic derivatives thereof ... health professionals, and researchers about the challenges of ... http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The Society ...
(Date:1/14/2014)...  RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology company ... addressing major unmet medical needs using RNA-targeted technologies, ... Allowance from the United States Patent and Trademark ... for the treatment of fibrosis. The patent covers ...
(Date:1/14/2014)... CA (PRWEB) January 14, 2014 Kerr Corporation, ... 10-minute video and additional how-to information about dual arch impressions ... Restorations with Dual Arch Impressions,” the blog entry serves up ... technique and houses a step-by-step demonstration by Dr. David Little ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3
... Summary: Genmab Reports Results for the First Three Months of ... today results for the three month period ended March 31, ... revenues were DKK 167 million (approx. USD 36 million) for ... Genmab recognized,revenues of DKK 80 million (approx. USD 17 million)., ...
... Md., May 28 Novavax, Inc. (Nasdaq:,NVAX) a clinical-stage ... Chief Executive Officer, will be presenting at the,FBR Capital ... on,May 29, 2008 at The Grand Hyatt Hotel in ... company,s strategy, research and development progress. A,link to the ...
... NanoLogix, Inc. (Pink,Sheets: NNLX) a nano-biotechnology company ... personnel will showcase company technology at booth 1304 ... June 1-5 2008. The ASM,meeting is the world,s ... Dr. Sergey Gazenko and CEO Bret Barnhizer.,Exhibition information ...
Cached Biology Technology:Genmab Announces 2008 First Quarter Results 2Genmab Announces 2008 First Quarter Results 3Genmab Announces 2008 First Quarter Results 4NanoLogix Inc. to Present at The American Society for Microbiology (ASM) General Meeting in Boston; Announces Product Line and Provides Operations Update 2
(Date:7/9/2014)... but often can be defeated with antibiotics and then ... Now, scientists have built a new weapon against such pathogens ... journal ACS Applied Materials & Interfaces , their study ... them than medicine alone. , David Leong, Jianping Xie and ... undetectable in the human body or in places that antibiotics ...
(Date:7/9/2014)... China challenges the commonly held belief that birds evolved ... fly. The birdlike fossil is actually not a dinosaur, ... a tiny tree-climbing animal that could glide, say American ... Utah, and Alan Feduccia of the University of North ... Ornithology . , The fossil of the Scansoriopteryx ...
(Date:7/9/2014)... is one of the amphibians with the highest distribution ... areas of water where it comes into contact with ... Research carried out by the Spaniard Germn Orizaola from ... of these frogs have developed a defensive response to ... larger bodies if they co-exist with the crayfish. , ...
Breaking Biology News(10 mins):Researchers declassify dinosaurs as being the great-great-grandparents of birds 2Frogs have developed rapid defences against the red swamp crayfish 2Frogs have developed rapid defences against the red swamp crayfish 3
... are blunt. In an attempt to eradicate tumors, oncologists ... healthy tissue along with the cancerous growths. New research ... bring scientists closer to designing cancer therapeutics that can ... last week in Science Express, follow a ...
... Although sildenafil is best known for promoting erections, it may also ... store more healthy "brown fat" relative to unhealthy "white fat" than ... research published online in The FASEB Journal , ... has been well known as a messenger molecule used by the ...
... MD FASEB MARC (Maximizing Access to Research Careers) ... Genetics Society of America (GSA) Drosophila Research Conference in ... meant to promote the entry of students, postdoctorates and ... basic science community and to encourage the participation of ...
Cached Biology News:Mechanism of mutant histone protein in childhood brain cancer revealed 2Drug for erectile disorder show promise in the treatment of obesity 2
Recombinant Equine IL-6...
... Checker Kits provide two highly efficient methods ... time-consuming plasmid preparation. By using the large-scale ... need to do is to transfer partial ... the transformation plates into the solutions provided ...
... Butcher (1998). • The major histocompatibility complex ... the immunology area. There is great interest ... in their function as antigen-presenting molecules. Many ... prospect of tackling biochemical and genetic techniques ...
actin from rabbit muscle Cell Biology Cytoskeletal Probes Actin and Actin Probes...
Biology Products: